APA (7th ed.) Citation

C, U., N, L., C, K., J, B., P, T., SD, Z., . . . R, M. (2025). Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany. PharmacoEconomics - open, 9(2), 291. https://doi.org/10.1007/s41669-024-00550-2

Chicago Style (17th ed.) Citation

C, Udeze, et al. "Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany." PharmacoEconomics - Open 9, no. 2 (2025): 291. https://doi.org/10.1007/s41669-024-00550-2.

MLA (9th ed.) Citation

C, Udeze, et al. "Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany." PharmacoEconomics - Open, vol. 9, no. 2, 2025, p. 291, https://doi.org/10.1007/s41669-024-00550-2.